Urologische Klinik


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Radiochemotherapy for invasive bladder cancer : An update (2018) Tselis N, Prott FJ, Ott O, Weiss C, Roedel C Journal article RECREATE: Treatment reality for mRCCpatients following first line Pazopanib therapy - a retrospective chart review (2018) Hegele A, Von Der Heyde E, Goebell P, Huebner A, Zengerling F, Klier J, Belz H, et al. Conference contribution Prospective evaluation of geriatric assessment tools as predictors of functional outcome in old patients undergoing major urologic tumor surgery (2018) Kahlmeyer A, Losensky W, Sikic D, Wach S, Ritt M, Goebell P, Keck B, Wullich B Conference contribution Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients (2018) Rot S, Kaune T, Greither T, Kotrba J, Bache M, Al-Nawas B, Vordermark D, et al. Conference contribution Analysis of androgen receptor mRNA expression in urothelial carcinoma of the bladder (2018) Sikic D, Wirtz R, Wach S, Dyrskjot L, Erben P, Bolenz C, Breyer J, et al. Conference contribution A multicenter comparison of PD-L1 protein and mRNA expression in urothelial bladder cancer by immunohistochemistry and RT-qPCR (Checkpoint-Typer(C)): A round robin test by the BRIDGE-Consortium Germany (2018) Eckstein M, Wirtz R, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, et al. Conference contribution Non-invasive bladder cancer (2018) Burger M, Schwaibold H, Goebell P, Grimm MO Journal article Metastatic castration-resistant prostate cancer. Use of cabazitaxel taking into consideration current data (2018) Gschwend JE, Albers P, Boegemann M, Goebell P, Heidenreich A, Klier J, Koenig F, et al. Journal article Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review (2018) Pinart M, Kunath F, Lieb V, Tsaur I, Wullich B, Schmidt S Journal article, Review article A randomised phase II study of Nivolumab plus Ipilimumab versus Standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2018) Ahrens M, Scheich S, Goekbuget N, Boleti E, Gruenwald V, Escudier B, Goebell P, et al. Conference contribution